Author

Elisabeth de Laguiche

Observed names: E. de Laguiche, Laguiche, Elisabeth de

Institution: Novo Nordisk (Denmark)

Observed institutions: Novo Nordisk (Denmark), Antenna Fondation

ORCID: 0000-0003-2125-9006

Observed ORCID: 0000-0003-2125-9006

OpenAlex ID: A5029039375

2023 · Marc Evans, Joanna de Courcy, et al. · International Journal of Obesity · 50

PDF

Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals

2023 · Jonathan Pearson-Stuttard, Tania Banerji, et al. · International Journal of Obesity · 35

PDF

Eight‐year trends in obesity‐related complications and health care cost progression in a US population with obesity: A retrospective cohort study

2022 · Marc Evans, Vamshi Ruthwik Anupindi, et al. · Diabetes Obesity and Metabolism · 18

PDF

Preventing nosocomial infections in resource-limited settings: An interventional approach in healthcare facilities in Burkina Faso

2020 · Pierre-Gilles Duvernay, Elisabeth de Laguiche, et al. · Infection Disease & Health · 11

PDF

FRI-196 Association between liver histology and long-term clinical outcomes in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease in Sweden: a real-world cohort study (BRIDGE-MASH)

2024 · Ying Shang, Johan Vessby, et al. · Journal of Hepatology · 3

Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan

2025 · Amy M. Jones, Pam Hallworth, et al. · Diabetes Therapy · 2

PDF

Correction to: Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan

2025 · Amy M. Jones, Pam Hallworth, et al. · Diabetes Therapy · 1

PDF

Environmental sustainability in diabetes: improving the quality of diabetes management through HTA and system-level change?

2025 · Melissa Pegg, Benjamin D. Bray, et al. · International Journal of Technology Assessment in Health Care · 1

PDF

AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes

2024 · Liana K. Billings, Marisse Asong, et al. · Diabetes Therapy · 1

PDF

Rural-urban disparities in the clinical diagnostic pathway of patients with all-cause mild cognitive impairment and dementia due to Alzheimer's disease in Australia

2026 · Xiaoping Lin, Mohammad Amin Honardoost, et al. · Journal of Alzheimer s Disease

Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon‐Like Peptide‐1 Receptor Agonist Versus a Fixed‐Ratio Combination Therapy: A Japanese Database Study

2026 · Takeshi Miyatsuka, James Brash, et al. · Diabetes Obesity and Metabolism

THU-206 Impact of fibrosis risk on health-related quality of life and activity in patients with metabolic dysfunction–associated steatohepatitis in Germany

2026 · Hayley Wallinger, Lena Amari, et al. · Journal of Hepatology

SAT-007 Economic and healthcare resource burden of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a United States system dynamics model

2026 · David W. Victor Iii, Amreen Dinani, et al. · Journal of Hepatology

TOP-002 Clinical and humanistic burden of metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis in the United States: a system dynamics model

2026 · Amreen Dinani, Elisabeth de Laguiche, et al. · Journal of Hepatology

Quantifying the Basal Insulin Treatment Preferences of People Living in Canada With Type 2 Diabetes When Glycemic Management and Cost Are Held Constant: A Discrete Choice Experiment

2026 · Pam Hallworth, Sophi Tatlock, et al. · Canadian Journal of Diabetes

Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain

2026 · Amy M. Jones, Pam Hallworth, et al. · Diabetes Obesity and Metabolism

PDF

Author response for "Preferences for basal insulin treatments in adults with type 2 diabetes: A discrete choice experiment in France and Spain"

2025 · Amy M. Jones, Pam Hallworth, et al.

Burden of diabetes-related comorbidities in people with type 2 diabetes on insulin in Japan: a real-world evaluation

2025 · E. de Laguiche, O. Kakade, et al. · Diabetes Research and Clinical Practice

PDF

Rural‐urban disparities in the diagnostic pathway of patients with all‐cause mild cognitive impairment or dementia due to Alzheimer's disease in Australia

2025 · Xiaoping Lin, Colman Taylor, et al. · Alzheimer s & Dementia

PDF

2025 · Takeshi Miyatsuka, Maiko Kino, et al. · Diabetes Therapy

PDF

RWD135 A Retrospective Observational Cohort Study to Investigate Uncontrolled Hyperglycemia and Delay in Basal Insulin Intensification and Non-Intensification Among Individuals With Type 2 Diabetes in Denmark

2024 · J.H. Rudolfsen, A. Gowda, et al. · Value in Health

PDF

RWD112 Therapeutic Inertia Among Individuals With Uncontrolled Type 2 Diabetes: A UK Population-Based Retrospective Analysis

2024 · S. Seidu, M. Asong, et al. · Value in Health

PCR211 Quantifying Patient Preferences for Type 2 Diabetes Basal Insulin Treatments: A Discrete Choice Experiment

2024 · P. Hallworth, C. Mottershead, et al. · Value in Health

PCR274 Exploring Drivers for Treatment Preferences in Canadian Patients With Type 2 Diabetes: A Qualitative Interview Study to Inform a Discrete Choice Experiment

2024 · A.M. Jones, S. Tatlock, et al. · Value in Health

Author response for "Eight‐year trends in obesity‐related complications and healthcare cost progression in a US population with obesity: a retrospective cohort study"

2022 · Marc Evans, Vamshi Ruthwik Anupindi, et al.

Works count: 26

Citation count: 122

H-index: 4

I10-index: 4